ASTRAZENECA A/S: Financial statements 2013
CVR: 55742928
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
ASTRAZENECA A/S (CVR 55742928) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 201,472,000 and a net result of DKK 5,806,000. The profit margin was 2.9%. Equity in the 2013 report amounted to DKK 124,604,000. The solvency ratio was 81.5%. The company had 102 employees in the financial year.
- Revenue
- DKK 201,472,000
- Gross Profit
- DKK 74,577,000
- Profit/Loss
- DKK 5,806,000
- Equity
- DKK 124,604,000
- Total Assets
- DKK 152,878,000
- Employees
- 102
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
ASTRAZENECA A/S has published its annual report for 2012.
About ASTRAZENECA A/S
ASTRAZENECA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1943. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Christof Josef Bischoff. The board consists of Emelie Karin Susanne Antoni (chair), Charlotte Ivang Ladefoged, Christof Josef Bischoff and Erik Jesper Bergkvist. The company is owned by AstraZeneca Continent BV and AstraZeneca AB. The company has 71 employees (2018). In 2025, the company reported revenue of DKK 630,320,000 and a net result of DKK 24,203,000 compared with DKK 6,241,000 the year before. Equity in the 2025 report amounted to DKK 226,831,000.